SS Innovations Appoints Naveen Kumar Amar as CFO

29th September, 2025

Amar brings to SS Innovations more than 25 years of global finance leadership experience spanning a wide range of industries and geographies

SS Innovations International, a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, announced the appointment of Naveen Kumar Amar as the Company’s Chief Financial Officer, effective September 24, 2025. Amar is assuming the Chief Financial Officer role, permanently, from Dr. Vishwa Srivastava, who has served as the Company’s Interim Chief Financial Officer since July 2025. Dr. Vishwa Srivastava will continue in his capacity as the Company’s Chief Executive Officer – Asia Pacific.

Amar brings to SS Innovations more than 25 years of global finance leadership experience spanning a wide range of industries and geographies. During his career, he has amassed expertise in financial accounting and reporting, planning and analysis, budgeting, forecasting, corporate finance, treasury operations, governance, internal controls, and both U.S. and Indian GAAP, among other areas. He has been recognized as one of India’s top financial executives by various publications and organizations, including Forbes India magazine, Forbes Asia magazine, CFO India Forum, and the Chartered Institute of Management Accountants, London.

Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, commented, “Amar brings to SS Innovations a strong track record of building best-in-class finance operations, effective cross-functional teams, and successful businesses across diverse industries and geographies. We are thrilled to welcome a seasoned financial executive of his caliber to our leadership team as we expand the global presence of our advanced, cost-efficient SSi Mantra surgical robotic system.”

Amar added, “I am honored to be joining SS Innovations at this exciting stage in its journey to democratize access to advanced surgical robotic care and I look forward to helping the team drive growth and deliver sustainable long-term shareholder value.”

Medtech Special

© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer